0001209191-11-056933.txt : 20111117 0001209191-11-056933.hdr.sgml : 20111117 20111117192855 ACCESSION NUMBER: 0001209191-11-056933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111115 FILED AS OF DATE: 20111117 DATE AS OF CHANGE: 20111117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-652-6500 MAIL ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS STEPHEN CENTRAL INDEX KEY: 0001131146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33734 FILM NUMBER: 111214490 MAIL ADDRESS: STREET 1: NEUROGEN CORP STREET 2: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-11-15 0 0001103390 Ardea Biosciences, Inc./DE RDEA 0001131146 DAVIS STEPHEN 4939 DIRECTORS PLACE SAN DIEGO CA 92121 0 1 0 0 EVP & COO Common Stock 2011-11-15 4 S 0 432 18.8563 D 17331 D The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 23, 2010. The range of sales prices received was $18.67 to $18.995. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Includes 576 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on November 14, 2011. /s/ Christian Waage Attorney-in-fact for Stephen Davis 2011-11-17